Tuberculin skin test and interferon-gamma release assay are currently recommended for the diagnosis of LTBI, but have a marginal role in the detection of TB cases, as they cannot distinguish between active and latent infection and may be influenced by the patient’s immune status. The gene discussed is IFNG; the disease is disease arising from reactivation of latent virus.